Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma
Public ClinicalTrials.gov record NCT01042704. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase I Study of Bendamustine in Combination With Lenalidomide (CC-5013) and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma
Study identification
- NCT ID
- NCT01042704
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Robert Redner, MD
- Other
- Enrollment
- 29 participants
Conditions and interventions
Conditions
Interventions
- Antibiotic Drug
- Aspirin Drug
- Bendamustine Drug
- Biweekly Follow Up Other
- Cyclical Follow Up Other
- Dexamethasone Drug
- Lenalidomide Drug
- Post-Treatment Follow Up Other
- Prophylaxis Drug
- Restaging Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2008
- Primary completion
- Dec 31, 2010
- Completion
- Feb 28, 2015
- Last update posted
- Jul 30, 2017
2008 – 2015
United States locations
- U.S. sites
- 22
- U.S. states
- 3
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| UPMC Cancer Centers - Teramana Cancer Center | Steubenville | Ohio | 43952 | — |
| UPMC Cancer Centers - Beaver | Beaver | Pennsylvania | 15009 | — |
| UPMC Cancer Centers - Jefferson | Clairton | Pennsylvania | 15025 | — |
| UPMC Cancer Centers - Arnold Palmer at Mountain View | Greensburg | Pennsylvania | 15601 | — |
| UPMC Cancer Centers - Arnold Palmer at Oakbrook | Greensburg | Pennsylvania | 15601 | — |
| UPMC Cancer Centers - Indiana | Indiana | Pennsylvania | 15701 | — |
| UPMC Cancer Centers - Johnstown | Johnstown | Pennsylvania | 15901 | — |
| Hematology-Oncology Associates of UPCI | McKeesport | Pennsylvania | 15132 | — |
| Hematology/Oncology - Private Practice | McKeesport | Pennsylvania | 15132 | — |
| UPMC Cancer Centers - Monroeville | Monroeville | Pennsylvania | 15146 | — |
| UPMC Cancer Centers - Arnold Palmer at Mt. Pleasant | Mount Pleasant | Pennsylvania | 15666 | — |
| UPMC Cancer Centers - New Castle | New Castle | Pennsylvania | 16105 | — |
| UPMC Cancer Centers - St. Margaret's | Pittsburgh | Pennsylvania | 15215 | — |
| UPMC Cancer Centers - Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | — |
| UPMC Cancer Centers - Passavant | Pittsburgh | Pennsylvania | 15237 | — |
| VA Healthcare System - 646 | Pittsburgh | Pennsylvania | 15240 | — |
| UPMC Cancer Centers - Drake | Pittsburgh | Pennsylvania | 15241 | — |
| UPMC Cancer Centers - Uniontown | Uniontown | Pennsylvania | 15401 | — |
| UPMC Cancer Centers - Washington | Washington | Pennsylvania | 15301 | — |
| UPMC Cancer Centers - North Hills | Wexford | Pennsylvania | 15090 | — |
| UPMC Cancer Centers - Windber | Windber | Pennsylvania | 15963 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01042704, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 30, 2017 · Synced May 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01042704 live on ClinicalTrials.gov.